Evaluation of Cryotherapy in Granuloma Pyogenicum
Launched by MEDICAL UNIVERSITY OF GRAZ · Jan 11, 2023
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a treatment called cryotherapy for a skin condition known as granuloma pyogenicum. Granuloma pyogenicum is a growth on the skin that can be bothersome, and the usual treatment involves surgery, which requires general anesthesia and can have risks. Cryotherapy, on the other hand, is a less invasive option that uses cold temperatures to treat the condition and can be done in a doctor’s office without needing anesthesia.
The trial is currently looking for participants aged 6 to 74 who have been diagnosed with granuloma pyogenicum. If you join the study, you can expect to receive cryotherapy and be monitored to see how well it works. It's important to know that participants cannot have had prior approval for cryotherapy treatment before joining the trial. Overall, this study aims to find out if cryotherapy is a safe and effective option for managing this skin condition without the need for surgery.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • diagnosis of granuloma pyogenicum
- Exclusion Criteria:
- • no approvement of cryotherapy
About Medical University Of Graz
The Medical University of Graz, a leading institution in Austria, is dedicated to advancing medical knowledge and improving patient care through innovative research and clinical trials. Renowned for its interdisciplinary approach, the university collaborates with various healthcare professionals and researchers to explore cutting-edge therapies and treatments. With a commitment to ethical standards and patient safety, the Medical University of Graz actively contributes to the global medical community by facilitating rigorous clinical trials that aim to translate scientific discoveries into practical applications for improved health outcomes.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Graz, Styria, Austria
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials